We are live on
!
Find out more
CCA
Conestoga Capital Advisors Portfolio holdings
AUM
$4.6B
1-Year Est. Return
16.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$969M
AUM Growth
–
Cap. Flow
+$935M
Cap. Flow
% of AUM
96.51%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
126
New
126
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CoStar Group
CSGP
|
+$39.3M |
| 2 |
RAVN
Raven Industries Inc
RAVN
|
+$31.9M |
| 3 |
Helios Technologies
HLIO
|
+$30.5M |
| 4 |
Tyler Technologies
TYL
|
+$29.8M |
| 5 |
EPAY
Bottomline Technologies Inc
EPAY
|
+$28M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.07% |
| 2 | Industrials | 16.54% |
| 3 | Healthcare | 13.83% |
| 4 | Materials | 8.03% |
| 5 | Consumer Discretionary | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Geospace Technologies
GEOS
$94.6M
| $18.9M | 1.95% |
+274,032
| New | +$22.9M |
|
|
HIBB
27
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $17.8M | 1.84% |
+320,039
| New | +$18M |
|
|
VIVO
28
DELISTED
Meridian Bioscience Inc
VIVO
| $17.5M | 1.8% |
+812,302
| New | +$17.5M |
|
29
Grand Canyon Education
LOPE
$3.79B
| $17.1M | 1.76% |
+529,619
| New | +$15.3M |
|
30
Aaon
AAON
$7.3B
| $16.6M | 1.71% |
+1,693,069
| New | +$15.2M |
|
31
Morningstar
MORN
$7.22B
| $16.5M | 1.7% |
+212,438
| New | +$14.7M |
|
32
NRC Health Common Stock
NRC
$432M
| $16.4M | 1.69% |
+910,042
| New | +$14.5M |
|
|
FARO
33
DELISTED
Faro Technologies
FARO
| $15.8M | 1.63% |
+468,217
| New | +$17.1M |
|
|
EGOV
34
DELISTED
NIC Inc
EGOV
| $15.5M | 1.6% |
+937,851
| New | +$16M |
|
|
ACCL
35
DELISTED
Accelrys Inc
ACCL
| $14.7M | 1.52% |
+1,754,920
| New | +$15.5M |
|
36
Factset
FDS
$9.36B
| $13.8M | 1.43% |
+135,677
| New | +$13M |
|
37
Acacia Research
ACTG
$428M
| $13.5M | 1.39% |
+604,383
| New | +$15.2M |
|
|
CRR
38
DELISTED
Carbo Ceramics Inc.
CRR
| $12.2M | 1.26% |
+181,126
| New | +$13.4M |
|
|
MCF
39
DELISTED
Contango Oil & Gas Co.
MCF
| $12M | 1.24% |
+355,740
| New | +$13.1M |
|
|
INWK
40
DELISTED
InnerWorkings, Inc.
INWK
| $10.7M | 1.11% |
+990,053
| New | +$11.3M |
|
41
Core Laboratories
CLB
$488M
| $10.2M | 1.05% |
+67,349
| New | +$9.54M |
|
42
Bio-Techne
TECH
$11.2B
| $10.1M | 1.05% |
+586,292
| New | +$9.73M |
|
43
Omnicell
OMCL
$1.61B
| $8.58M | 0.89% |
+417,531
| New | +$7.71M |
|
44
Medifast
MED
$109M
| $8.56M | 0.88% |
+332,394
| New | +$8.73M |
|
45
NVE Corp
NVEC
$562M
| $8.34M | 0.86% |
+178,107
| New | +$9.17M |
|
46
AeroVironment
AVAV
$7.56B
| $7.95M | 0.82% |
+394,070
| New | +$7.66M |
|
47
SPS Commerce
SPSC
$2.64B
| $5.48M | 0.57% |
+199,226
| New | +$4.81M |
|
|
NRCIB
48
DELISTED
National Research Corp Class B
NRCIB
| $5.3M | 0.55% |
+151,647
| New | +$5.34M |
|
49
ExxonMobil
XOM
$644B
| $3.98M | 0.41% |
+44,038
| New | +$3.96M |
|
50
Mesa Laboratories
MLAB
$564M
| $3.79M | 0.39% |
+70,040
| New | +$3.63M |
|
Similar funds
SCM
AG
LNWTC
ANTB
SV
DWM
SCM
VCM
Conestoga Capital Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Conestoga Capital Advisors, which disclosed 126 positions worth $969M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is CoStar Group: 3,475,900 shares worth $44.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Industrials and Healthcare.
- Conestoga Capital Advisors's largest Q2 2013 buy was CoStar Group: 3,475,900 shares worth $44.9M.
- Conestoga Capital Advisors's ten largest holdings make up 31% of its $969M portfolio in Q2 2013.
- Conestoga Capital Advisors disclosed 126 positions in Q2 2013, its first 13F filing on record.
Based on Conestoga Capital Advisors's 13F filing for Q2 2013, filed 29 Jul 2013.